U.S. Pharmacopeia (USP), Maryland
Julian Chesterman, PhD is a Scientist III at U.S. Pharmacopeia (USP). His background is in the synthesis, purification, characterization, and scale-up of polymers for use in pharmaceutical formulations and medical devices. At USP, he is evaluating advanced analytical techniques for the characterization of polymeric excipients. Julian completed his PhD in Chemical Engineering with a Specialization in Biomedical Engineering at Queen’s University in Canada under Dr. Brian G. Amsden. His PhD thesis focused on developing novel reversibly photo-crosslinkable polymeric drug delivery vehicles for the treatment of ocular diseases, such as age-related macular degeneration (AMD). Prior to joining USP, he spent two years as a Postdoctoral Associate at the New Jersey Center for Biomaterials (Rutgers University) under Dr. Joachim Kohn, researching novel tyrosine and tyrosol-derived biodegradable polymers. He has co-authored 5 peer-reviewed journal articles and a book chapter and presented his research at major conferences including the 250th American Chemical Society National Meeting and the 10th World Biomaterials Congress.
Wednesday, November 11, 2020
11:10 AM – 11:30 AM ET